Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Oral Solid Dosage Contract Manufacturing Market

Oral Solid Dosage Contract Manufacturing Market Share

Report ID: GMI9169
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Oral Solid Dosage Contract Manufacturing Market Share

The oral solid dosage contract manufacturing industry is characterized by intense competition among key players striving to strengthen their foothold in the market. Key market players frequently undertake inorganic growth initiatives such as partnerships, mergers, and acquisitions to expand their market presence, enhance service portfolios, and gain a competitive advantage.

Oral Solid Dosage Contract Manufacturing Market Companies

Prominent players operating in the oral solid dosage contract manufacturing industry include:

Aenova Group
AbbVie Contract Manufacturing (AbbVie Inc.)
Boehringer Ingelheim International GmbH
Catalent, Inc.
Corden Pharma International
Jubilant Pharmova Limited
Lonza
NextPharma Technologies
Patheon Pharma Services (Thermo Fisher Scientific Inc.)
Siegfried Holding AG

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Oral solid dosage contract manufacturing market size was USD 35.6 billion in 2023 and is expected to register 5.6% CAGR from 2024-2032 owing to the rising trend of outsourcing manufacturing by pharmaceutical companies worldwide.

Oral solid dosage contract manufacturing industry from the tablets segment reached USD 11.6 billion in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to their convenience, ease of administration, and patient compliance.

North America oral solid dosage contract manufacturing industry is expected to register 5.3% CAGR from 2024-2032 due to advanced healthcare infrastructure, stringent regulatory framework, and the presence of prominent pharmaceutical companies in the region.

Aenova Group, Catalent, Inc., Corden Pharma International, Jubilant Pharmova Limited, Lonza, NextPharma Technologies, Patheon Pharma Services (Thermo Fisher Scientific Inc.), and Siegfried Holding AG, are some of the major oral solid dosage contract manufacturing companies worldwide.